[Infectious endocarditis].
Pilz
B
B
Franz-Volhard-Klinik, Max-Delbrück-Centrum für Molekulare Medizin, Charité, Humboldt-Universität, Berlin. pilz@fvk-berlin.de
von  Harsdorf
R
R
Dietz
R
R
Osterziel
K J
KJ
D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001769:Blood / Q000382:microbiology; D004359:Drug Therapy, Combination; D004452:Echocardiography; D004697:Endocarditis, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D016983:Enterococcus / Q000302:isolation & purification; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects; D006801:Humans; D016867:Immunocompromised Host; D011379:Prognosis; D012307:Risk Factors; D013211:Staphylococcus aureus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D019966:Substance-Related Disorders / Q000150:complications; D013997:Time Factors
D000890:Anti-Infective Agents